Leap Therapeutics Stock Story
| LPTX Stock | USD 3.29 0.09 2.81% |
Slightly above 71 percent of all Leap Therapeutics' investors are curious in acquiring. The analysis of the overall investor sentiment regarding Leap Therapeutics suggests that a large number of traders are confidant. Leap Therapeutics' investor sentiment overview provides quick insight into current market opportunities from investing in Leap Therapeutics. The current market sentiment, together with Leap Therapeutics' historical and current headlines, can help investors time the market. In addition, many technical investors use Leap Therapeutics stock news signals to limit their universe of possible portfolio assets and to time the market correctly.
Leap Therapeutics stock news, alerts, and headlines are usually related to its technical, predictive, social, and fundamental indicators. It can reflect on the current distribution of Leap daily returns and investor perception about the current price of Leap Therapeutics as well as its diversification or hedging effects on your existing portfolios.
Leap |
Requested story not found. it has been either deleted or moved. View all stories for Leap Therapeutics.
Leap Therapeutics Latest Timeline
Leap Therapeutics is listed for 3.29. About 16.0% of the company outstanding shares are owned by corporate insiders. The company has price-to-book ratio of 1.4. Typically companies with comparable Price to Book (P/B) are able to outperform the market in the long run. Leap Therapeutics has Price/Earnings To Growth (PEG) ratio of 0.75. The entity recorded a loss per share of 3.98. The firm had not issued any dividends in recent years. Leap Therapeutics had 1:10 split on the 21st of June 2023.Check out Leap Therapeutics Hype Analysis, Leap Therapeutics Correlation and Leap Therapeutics Performance. For more information on how to buy Leap Stock please use our How to Invest in Leap Therapeutics guide.You can also try the Earnings Calls module to check upcoming earnings announcements updated hourly across public exchanges.
Complementary Tools for Leap Stock analysis
When running Leap Therapeutics' price analysis, check to measure Leap Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Leap Therapeutics is operating at the current time. Most of Leap Therapeutics' value examination focuses on studying past and present price action to predict the probability of Leap Therapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Leap Therapeutics' price. Additionally, you may evaluate how the addition of Leap Therapeutics to your portfolios can decrease your overall portfolio volatility.
| Portfolio Dashboard Portfolio dashboard that provides centralized access to all your investments | |
| Portfolio Optimization Compute new portfolio that will generate highest expected return given your specified tolerance for risk | |
| Correlation Analysis Reduce portfolio risk simply by holding instruments which are not perfectly correlated | |
| Piotroski F Score Get Piotroski F Score based on the binary analysis strategy of nine different fundamentals | |
| AI Portfolio Architect Use AI to generate optimal portfolios and find profitable investment opportunities | |
| ETF Categories List of ETF categories grouped based on various criteria, such as the investment strategy or type of investments | |
| Competition Analyzer Analyze and compare many basic indicators for a group of related or unrelated entities |
Is Leap Therapeutics' industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Leap Therapeutics. If investors know Leap will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Leap Therapeutics listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (3.98) | Revenue Per Share 0.003 | Return On Assets (0.75) | Return On Equity (1.37) |
The market value of Leap Therapeutics is measured differently than its book value, which is the value of Leap that is recorded on the company's balance sheet. Investors also form their own opinion of Leap Therapeutics' value that differs from its market value or its book value, called intrinsic value, which is Leap Therapeutics' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Leap Therapeutics' market value can be influenced by many factors that don't directly affect Leap Therapeutics' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Leap Therapeutics' value and its price as these two are different measures arrived at by different means. Investors typically determine if Leap Therapeutics is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Leap Therapeutics' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.